ST

Surbudeen Thajudeen

Active Director Director DIN 10824209
DIN 10824209 First appointment Oct 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Surbudeen Thajudeen

Data last updated:

Surbudeen Thajudeen is a Director at Tals Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10824209
Primary Designation Director
Industry Pharma
First Appointment 29 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tals Pharmaceuticals Private Limited U47721TZ2024PTC032832
Director29 Oct 20242024Active

Board colleagues of Surbudeen Thajudeen

NameDINCompanyDesignation
Kumar Subathra10824208Tals Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Tals Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Surbudeen Thajudeen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surbudeen Thajudeen

Surbudeen Thajudeen currently holds 1 directorship: Tals Pharmaceuticals Private Limited (Director, since 29 Oct 2024).

Surbudeen Thajudeen was first appointed on 29 Oct 2024 as Director at Tals Pharmaceuticals Private Limited.

The current boards of Surbudeen Thajudeen's companies include Kumar Subathra (Tals Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available